Newly developed COVID-19 test detects and identifies specific variants with 100% accuracy
University of California, Irvine researchers have developed a COVID-19 test that detects and identifies specific SARS-CoV-2 variants with 100% accuracy. In a study, the RNA-encoded viral nucleic acid analytic reporter correctly determined the Alpha, Gamma, Delta, Epsilon and Omicron genetic mutations in nasopharyngeal clinical samples. This ability could enable healthcare providers to make personalized treatment decisions for improved patient care.